# CELESTICA INC. (CLS) · Edgar & Edgarette company card

> Celestica (CLS) grew revenue 28.5% in FY2025 to $12.4 billion, operating margin 8.4% against a 4.6% median for printed circuit boards, equity 30.7% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1030894 · fiscal year ended 2025-12-31 · 4 audited years read · [page](https://www.pops4.com/boards/company/CLS) · [JSON](https://www.pops4.com/boards/company/CLS.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $12.4B |
| Revenue growth, 1 year | 28.5% |
| Revenue growth per year | 19.6% |
| Operating margin | 8.4% (prior year 6.2%) |
| Net margin | 6.7% |
| Operating cash flow | $660M |
| Capital spending | $201M |
| Free cash flow | $458M |
| Cash | $596M |
| Long-term debt | $777M |
| Total assets | $7.2B |
| Total equity | $2.2B |
| Equity ÷ assets | 30.7% |
| Return on equity | 37.6% |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: 3.2 (safe zone)
- Piotroski F: 7 of 9 (solid)
- Health Harbor boat: New ship · no warning signs
- Cash Compass: Fast, cash not yet · growing fast, but little cash arriving so far

## Edgarette's reading

Exposure: revenue $12.4B (FY2025), total debt $776.5M. Experience: revenue up 28.5% on the year, up 19.6% a year over 3 years; operating margin 8.4%, up from 6.2%. Soundness: equity 30.7% of assets, return on equity 37.6%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $13.5B and $16.4B next year (method v4.1: its own 3-year record of growth weighed at 40% against $10B+ filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $12.4B to $17.7B. A statistical range, not company guidance. Against peers (10 filers, $50M+ revenue, printed circuit boards): operating margin 8.4% against a 4.6% median; growth 28.5% against 6.3%.

Range logged 2026-09-25, receipt 95e6f8e613cf08ec, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 5.02 Director or officer change: 4, latest 2026-09-11 ([filing](https://www.sec.gov/Archives/edgar/data/1030894/000110465926107079/0001104659-26-107079-index.htm))

## Recent filings

- 8-K · filed 2026-10-30 · 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1030894/000103089426000054/0001030894-26-000054-index.htm)
- 8-K · filed 2026-10-27 · 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1030894/000110465926118978/0001104659-26-118978-index.htm)
- 10-Q · filed 2026-10-26 · [filing](https://www.sec.gov/Archives/edgar/data/1030894/000103089426000050/0001030894-26-000050-index.htm)
- 8-K · filed 2026-10-26 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1030894/000103089426000049/0001030894-26-000049-index.htm)
- 8-K · filed 2026-09-11 · 5.02 Departure or Election of Directors; Appointment of Officers; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1030894/000110465926107079/0001104659-26-107079-index.htm)
- 8-K · filed 2026-08-07 · 1.01 Entry into a Material Definitive Agreement; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1030894/000110465926092676/0001104659-26-092676-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001030894.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1030894

## Cite

POPS4, Edgar & Edgarette: CELESTICA INC. (CLS) company card, from the company's own SEC filings, accessed 2026-11-04, https://www.pops4.com/boards/company/CLS. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.